Patents
New patent covers antiviral compounds
Published in Hepatitis Weekly, September 23rd, 2002
U.S. Patent No. 6399654 (Biflavanoids and derivatives thereof as antiviral agents) bolsters the company's proprietary position in biflavanoids as potential antiviral drugs.
The biflavanoids are a class of compounds, derived from natural products, which have demonstrated in vitro biological activity in hepatitis B (HBV) and other viral diseases. Hepatitis B is one of the most common and serious infections in the world, with an estimated 350 million people that are chronic carriers. It is also estimated that 5% of the world...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-09-23)
More Articles from Hepatitis Weekly
- Hepatitis B Therapy
Regimens altering lamivudine and interferon yield similar results in children - Proficiency Testing
Although hepatitis C assays are good, there is still room for improvement - Hepatitis B Therapy
New inhibitors show promise for eradicating hepatitis drug-resistant mutants - Hepatitis B Vaccine
Hip or thigh yield comparable vaccine protection in immunized infants - Kidney Failure
Hepatitis B vaccine best administered to children before end-stage liver disease - Appointments
Bill Forbes joins tapped as VP - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
